Biotechnology

Biotechnology Healthcare Investing News Life Style Market News Medical Use Pharmaceutical Products The Market Buzz Your Environment

Merck Seeks Emergency Use Authorization for its Oral Covid-19 Treatment

Rebecca Urena10/11/2021

140

Merck (NYSE: MRK), an American pharmaceutical company, is seeking emergency use authorization from the Food and Drug Administration for its preliminary antiviral Covid-19 pill, molnupiravir, used to treat mild...

Biotechnology Healthcare Investing News Life Style Market News Medical Use Pharmaceutical Products The Market Buzz Your Environment

Pfizer Covid Booster Shots Receive FDA Approval for People 65 and Older

Rebecca Urena09/23/2021

230

The Food and Drug Administration has granted emergency use authorization to Pfizer (NYSE: PFE) and BioNtech for its Covid-19 booster shots in people 65 years and older as well...

Biotechnology Healthcare Investing News Life Style Market News Medical Use Pharmaceutical Products The Market Buzz Your Environment

Moderna Announces Development of Single-Dose Booster for Covid and Flu

Rebecca Urena09/09/2021

253

Modena (NASDAQ: MRNA) shares rose over 5% on Thursday after announcing it is developing a single-shot vaccine booster shot for both Covid-19 and the flu. According to a press...

Biotechnology Healthcare Investing News Life Style Market News Medical Use Pharmaceutical Products The Market Buzz Your Environment

A Study Concludes Blood Clots Linked to AstraZeneca Vaccine are ‘Rare but Devastating’

Rebecca Urena08/12/202108/12/2021

212

A new study with information regarding the “rare but devastating” blood clotting issue affiliated with the Oxford-AstraZeneca (OTCMKTS: AZNCF) Covid-19 vaccine has been released. Nevertheless, according to British scientists,...

Biotechnology Healthcare Investing News Life Style Market News Medical Use Pharmaceutical Products The Market Buzz Your Environment

Pfizer Reports $7.8 Billion in Covid Vaccines Sales During Q2

Rebecca Urena07/28/2021

298

Pfizer (NYSE: PFE) disclosed better-than expected earnings and revenue Wednesday after having sold USD7.8 Billion in Covid-19 vaccines throughout the second quarter. Due to the continued spread of the...

Biotechnology Healthcare Investing News Market News Medical Use Pharmaceutical Products The Market Buzz

Johnson & Johnson Reports Better-than-Expected Earnings

Rebecca Urena07/21/2021

120

Johnson & Johnson (NYSE: JNJ) released its second-quarter financial results on Wednesday, with earnings and revenue surpassing Wall Street expectations. The company now anticipates to sell USD2.5 Billion of...

Biotechnology Healthcare Investing News Market News Medical Use Pharmaceutical Products The Market Buzz

Moderna to Join the S&P 500

Rebecca Urena07/16/2021

149

Moderna (NASDAQ: MRNA), an American pharmaceutical company best known for its Covid-19 vaccine, is being added to the S&P 500 Index later this month. The news is set to...

Biotechnology Healthcare Investing News Life Style Market News Medical Use Pharmaceutical Products The Market Buzz Your Environment

FDA to Place Warning on J&J Covid-19 Vaccine Regarding Rare Disorder

Rebecca Urena07/13/202107/13/2021

280

The Food and Drug Administration (FDA) revealed it would be placing a warning on the Johnson & Johnson Covid-19 (NYSE: JNJ) vaccine, as the shot has been associated with...

Biotechnology Healthcare Investing News Life Style Market News Medical Use Pharmaceutical Products The Market Buzz Your Environment

Eli Lilly Seeks to Cut Insulin Costs as Walmart Debuts Lower-Price Rival

Rebecca Urena06/29/2021

357

Walmart introduced a less expensive version of analog insulin and Eli Lilly (NYSE: LLY) CEO David Ricks revealed it is ready for the competition. Walmart announced Tuesday that it is...

Biotechnology Healthcare Investing News Life Style Market News Medical Use Pharmaceutical Products The Market Buzz Your Environment

FDA adds Heart Inflammation Warning on Pfizer & Moderna Covid Vaccines

Rebecca Urena06/28/2021

378

On Friday, the U.S. Food and Drug Administration added a warning to Moderna and Pfizer-BioNTech Covid-19 vaccines regarding a rare risk of heart inflammation. Pfizer and Moderna’s fact sheets...

Merck Seeks Emergency Use Authorization for its Oral Covid-19 Treatment

Pfizer Covid Booster Shots Receive FDA Approval for People 65 and Older

Moderna Announces Development of Single-Dose Booster for Covid and Flu

A Study Concludes Blood Clots Linked to AstraZeneca Vaccine are ‘Rare but Devastating’

Pfizer Reports $7.8 Billion in Covid Vaccines Sales During Q2

Johnson & Johnson Reports Better-than-Expected Earnings

Moderna to Join the S&P 500

FDA to Place Warning on J&J Covid-19 Vaccine Regarding Rare Disorder

Eli Lilly Seeks to Cut Insulin Costs as Walmart Debuts Lower-Price Rival

FDA adds Heart Inflammation Warning on Pfizer & Moderna Covid Vaccines

The Buzz Surrounding First Responder Technologies Inc.

Entertainment One and Alibaba Pictures Announce Joint Production to Bring Peppa Pig to Theaters in China

Environmental Class Action Plaintiffs Achieve Major Victory in Federal Appeals Court

Spanx Valued at USD1.2 Billion After Blackstone Deal

Beyond Meat Plunges After Cutting Third-Quarter Revenue Forecast

WeWork Goes Public Through SPAC Deal

Latest Tweets